wiki pageCreated: 2026-04-02T07:20:07By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-companies-imbd-taiwan
📖 Wiki Page
company592 wordssynced 2026-04-02
IMBD (Institute of Molecular Biology, Taiwan)
Overview
The Institute of Molecular Biology (IMB) at Academia Sinica, Taiwan, is a premier research institute focused on molecular biology and biotechnology research, with significant contributions to neurodegenerative disease research. The institute represents Taiwan's flagship research institution for molecular neuroscience and drug discovery[@academia][@institute].
Institute Information
| Detail | Value | |--------|-------| | Headquarters | Taipei, Taiwan | | Parent Organization | Academia Sinica | | Focus | Molecular biology, biotechnology, neurodegenerative diseases | | Founded | 1983 | | Director | Dr. James C. K. Chen |
Research Focus Areas
Molecular Mechanisms of Neurodegeneration
The institute conducts fundamental research on:
Protein aggregation mechanisms: Understanding how misfolded proteins like alpha-synuclein and tau form toxic aggregates
Neuronal death pathways: Apoptosis, necroptosis, and other cell death mechanisms in neurodegeneration
Cellular stress responses: Unfolded protein response, oxidative stress, and mitochondrial dysfunction
Gene Discovery and Validation
Genetic epidemiology: Identifying genetic risk factors in Parkinson's disease in Asian populations
Functional genomics: Characterizing the role of risk genes using cellular and animal models
Target validation: Moving from gene discovery to therapeutic target identification
Drug Discovery
...
IMBD (Institute of Molecular Biology, Taiwan)
Overview
The Institute of Molecular Biology (IMB) at Academia Sinica, Taiwan, is a premier research institute focused on molecular biology and biotechnology research, with significant contributions to neurodegenerative disease research. The institute represents Taiwan's flagship research institution for molecular neuroscience and drug discovery[@academia][@institute].
Institute Information
| Detail | Value | |--------|-------| | Headquarters | Taipei, Taiwan | | Parent Organization | Academia Sinica | | Focus | Molecular biology, biotechnology, neurodegenerative diseases | | Founded | 1983 | | Director | Dr. James C. K. Chen |
Research Focus Areas
Molecular Mechanisms of Neurodegeneration
The institute conducts fundamental research on:
Protein aggregation mechanisms: Understanding how misfolded proteins like alpha-synuclein and tau form toxic aggregates
Neuronal death pathways: Apoptosis, necroptosis, and other cell death mechanisms in neurodegeneration
Cellular stress responses: Unfolded protein response, oxidative stress, and mitochondrial dysfunction
Gene Discovery and Validation
Genetic epidemiology: Identifying genetic risk factors in Parkinson's disease in Asian populations
Functional genomics: Characterizing the role of risk genes using cellular and animal models
Target validation: Moving from gene discovery to therapeutic target identification
LRRK2 (Leucine-rich repeat kinase 2) is a major genetic contributor to familial PD. The institute studies:
LRRK2 kinase activity and regulation
LRRK2 mutations and their functional consequences
LRRK2 inhibitor development[@polymeropoulos2017]
Mitochondrial Dysfunction
Research on energy metabolism defects in dopaminergic neurons:
Complex I deficiency in PD
PINK1/Parkin mitophagy pathway
mtDNA mutations and copy number changes
Metabolic reprogramming in neurodegeneration
Neuroinflammation
Glial cell contributions to PD progression
[Microglia](/cell-types/microglia)l activation states
Cytokine and chemokine signaling
Peripheral immune system interactions
Key Programs
| Program | Focus Area | Status | |---------|------------|--------| | Alpha-synuclein project | Protein aggregation | Active research | | LRRK2 signaling | Signal transduction | Active research | | Mitochondrial biology | Energy metabolism | Active research | | Neuroinflammation | Glial biology | Active research | | Drug discovery | Compound screening | Pipeline development |
Key Researchers and Groups
Dr. Hsiu-Ming Shih — Neurobiology and cell biology
Dr. Ren-Huang Wang — Parkinson's disease genetics
Dr. Ming-Fa Hsieh — Drug discovery and natural products
Collaborations
IMBD maintains extensive research collaborations:
National Taiwan University — Medical school and research partnerships
Taipei Medical University — Clinical research and translational work
Chang Gung University — Neuroscience research
International collaborations — With NIH, MRC, and other global institutions
Core Facilities
The institute provides shared research resources:
Genomics Core — Next-generation sequencing and bioinformatics
Proteomics Core — Mass spectrometry and protein analysis
Cell Imaging Core — Confocal and live-cell imaging
Animal Facility — Transgenic and knockout mouse models